Novavax, Inc. (NVAX)

6.825 +0.04 (+0.66%) USD  |  NASDAQ  |  Dec 09, 11:50
More

Novavax EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Arcturus Therapeutics Holdings, Inc. Upgrade